Giant%20Cell%20Tumors
Showing 9976 - 10000 of >10,000
CD19+ and CD 22+ B-ALL Trial in Langfang (Autologous CD19/CD22 Chimeric Antigen Receptor T-cells, Cyclophosphamide,Fludarabine)
Recruiting
- CD19+ and CD 22+ B-ALL
- Autologous CD19/CD22 Chimeric Antigen Receptor T-cells
- Cyclophosphamide,Fludarabine
-
Langfang, Hebei, ChinaHebei Yanda Ludaopei Hospital
Jan 25, 2022
Stem Cell Transplantation Trial in Houston (Fludarabine, Dexamethasone, Cyclophosphamide)
Not yet recruiting
- Stem Cell Transplantation
- Fludarabine
- +9 more
-
Houston, TexasM D Anderson Cancer Center
May 4, 2022
BIOREN (Predictive BIOmarkers in Metastatic RENal Cancer)
Recruiting
- Renal Cancer Metastatic
- Immunological and tumour characterization
-
Lyon, FranceCentre Leon Berard
Mar 14, 2022
DOCK8 Deficiency Trial run by the National Cancer Institute (NCI) (Reduced-intensity hematopoietic stem cell,
Recruiting
- DOCK8 Deficiency
- Reduced-intensity hematopoietic stem cell
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Diabetic Neuropathies Trial in Frankfurt (Intraarterial bone marrow progenitor cell transplantation)
Completed
- Diabetic Neuropathies
- Intraarterial bone marrow progenitor cell transplantation
-
Frankfurt, GermanyDiv. of Cardiology and Vascular Medicine
Oct 18, 2021
Adenovirus Infections in Allogenic Hematopoietic Cell Transplant
Completed
- Adenovirus Infections, Human
- (no location specified)
Mar 10, 2022
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer Trial in
Active, not recruiting
- Adult Primary Hepatocellular Carcinoma
- +2 more
- sorafenib tosylate
- stereotactic body radiation therapy
-
Berkeley, California
- +50 more
Nov 17, 2022
Severe Malaria, Malaria,Falciparum, Acute Kidney Injury Trial in Kinshasa (Paracetamol, Mechanical antipyresis)
Recruiting
- Severe Malaria
- +3 more
- Paracetamol
- Mechanical antipyresis
-
Kinshasa, Congo, Congo, The Democratic Republic of theThe Kinshasa Medical Oxford Research Unit (KIMORU)
Feb 17, 2022
Tumors of the CNS Trial in Boston (18F-FLT, PET Imaging)
Terminated
- Tumors of the Central Nervous System
- 18F-FLT
- PET Imaging
-
Boston, MassachusettsChildren's Hospital Boston
Oct 12, 2021
Host Microbiota and Il-17 in Favoring Multiple Myeloma
Recruiting
- Multiple Myeloma
-
Milan, Milano, ItalyIRCCS Ospedale San Raffaele
Jan 26, 2023
HPV in Sinonasal Ca: Retrospective Analysis Association of Human
Recruiting
- Sinonasal Carcinoma
- HPV-Related Squamous Cell Carcinoma
-
Baltimore, MarylandJohns Hopkins University
Jul 28, 2022
Prostate Cancer Metastatic Trial in Leiden (Enzalutamide, 18-FDG PET/CT, Whole body MRI)
Completed
- Prostate Cancer Metastatic
- Enzalutamide
- +3 more
-
Leiden, NetherlandsLeiden University Medical Center
Apr 6, 2022
Cytomegaloviral Infection, Hematopoietic Cell Transplant Recipient Trial in Duarte (Laboratory Biomarker Analysis, Multi-peptide
Recruiting
- Cytomegaloviral Infection
- Hematopoietic Cell Transplant Recipient
- Laboratory Biomarker Analysis
- Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 14, 2022
Hematopoietic Stem Cell Transplantation (HSCT), Acute GVH Disease Trial in Boston (Vancomycin-polymyxin B)
Active, not recruiting
- Hematopoietic Stem Cell Transplantation (HSCT)
- Acute GVH Disease
- Vancomycin-polymyxin B
-
Boston, Massachusetts
- +1 more
Jan 28, 2022
CNS B-Cell Non-Hodgkin Lymphoma, Recurrent CNS Lymphoma, Refractory CNS Lymphoma Trial in Houston (Ibrutinib, Nivolumab)
Recruiting
- Central Nervous System B-Cell Non-Hodgkin Lymphoma
- +2 more
- Ibrutinib
- Nivolumab
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2022
Solid Tumors Harboring NTRK Fusion Trial in Worldwide (Larotrectinib (Vitrakvi, BAY2757556))
Recruiting
- Solid Tumors Harboring NTRK Fusion
- Larotrectinib (Vitrakvi, BAY2757556)
-
Los Angeles, California
- +50 more
Jan 29, 2023
Gastric Cancer, Gastroesophageal-junction Cancer, Esophageal Cancer Trial (LB1908)
Not yet recruiting
- Gastric Cancer
- +3 more
- LB1908
- (no location specified)
Sep 9, 2022
NSCLC Trial in Kashiwa, Miyakojima-ku, Sunto District (Poziotinib Once Daily Dosing, Poziotinib Twice Daily Dosing, Poziotinib
Recruiting
- NSCLC
- Poziotinib Once Daily Dosing
- +2 more
-
Kashiwa, Chiba, Japan
- +2 more
Jan 7, 2022
Non Hodgkin Lymphoma (NHL), Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL) Trial in Milwaukee (8/12-Day
Recruiting
- Non Hodgkin Lymphoma (NHL)
- +6 more
- 8/12-Day Production of Car-T Cells
- +2 more
-
Milwaukee, WisconsinMedical College of Wisconsin and Froedtert Hospital
Jul 1, 2022
Metastatic Breast Cancer, HER2 Positive Breast Carcinoma Trial in United States (Niraparib, Trastuzumab)
Recruiting
- Metastatic Breast Cancer
- HER2 Positive Breast Carcinoma
-
Birmingham, Alabama
- +6 more
Dec 13, 2022
Neuroendocrine Tumors Trial in Sherbrooke (Gallium-68 DOTA TATE PET scan)
Completed
- Neuroendocrine Tumors
- Gallium-68 DOTA TATE PET scan
-
Sherbrooke, Quebec, CanadaCentre hospitalier universitaire de Sherbrooke
May 17, 2021
Displacement Distance and Stabilization Time for Liver Fiducial
Recruiting
- Liver Cancer
-
Beijing, United Kingdom Of Great Britain And Northern Ireland, China
- +1 more
Apr 4, 2023